Representative Matters

  • Assisting a pharmaceutical company in an internal investigation prompted by a former employee’s wrongful termination lawsuit
  • Representing investors and trustees of several residential mortgage-backed securities (RMBS) trusts in multiple loan repurchase cases pending in New York State and federal courts and in Delaware Chancery Court
  • Representing several individuals in investigations by the Securities and Exchange Commission (SEC), Office of the Special Inspector General for the Troubled Asset Relief Program (SIGTARP), FINRA, and the U.S. Department of Justice (DOJ) regarding RMBS trading
  • Representing sales personnel and traders in several benchmark manipulation investigations by the SEC, the DOJ, and the Commodity Futures Trading Commission (CFTC)
  • Providing representation to the head of an equities desk in an investigation regarding alleged deficiencies in an investment bank’s anti-money laundering controls
  • Representing a national construction company in a federal criminal investigation involving the federal government’s Disadvantaged Business Enterprise program
  • Assisting an investment management firm in investigations by the CFTC, the SEC, and the DOJ
  • Representing a pharmaceutical company in a False Claims Act and Anti-Kickback Statute qui tam action alleging improper marketing activities and wrongful termination, which resulted in a negotiated resolution
  • Providing representation to a U.S.-based medical device manufacturer company in Foreign Corrupt Practices Act investigations involving Mexico and Brazil
  • Assisting a pharmaceutical company with an internal investigation of potential off-label marketing practices, safety issues, and HIPAA violations
  • Representing a multinational pharmaceutical company in a False Claims Act qui tam action in which the government declined to intervene